A retrospective analysis of postpartum red blood cell transfusions at a tertiary care obstetric centre.
blood transfusion
postpartum anaemia
postpartum haemorrhage
Journal
Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606
Informations de publication
Date de publication:
26 Jun 2024
26 Jun 2024
Historique:
revised:
26
04
2024
received:
02
01
2024
accepted:
06
06
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
26
6
2024
Statut:
aheadofprint
Résumé
Postpartum anaemia is a prevalent health problem. We aimed to determine the compliance rate for red blood cell (RBC) transfusion indication among postpartum women in a single tertiary care centre in Quebec, Canada. Retrospective cohort study including all women ≥6 h postpartum who received ≥1 RBC transfusion during their delivery hospitalization between January 2005 and February 2022. We determined our centre's compliance rate by indication as compared to current society guidelines, all published after 2015 (Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis [NATA], Royal College of Obstetricians and Gynaecologists [RCOG], American College of Obstetricians and Gynecologists [ACOG]). We then explored predictors of guideline non-compliance and described transfusion practices in our centre. A total of 171 women were included. Our centre's compliance rate was 79.5% (95% confidence interval [CI] 72.7-84.8). Predictors of guideline non-compliance were maternal medical comorbidity or abnormal placentation, both limited by large CIs (odds ratio [OR] 2.26, CI 1.02-4.94, p = 0.04; OR 4.00, CI 1.31-12.06, p = 0.01, respectively). Postpartum haemorrhage was diagnosed among 68% of the cohort, mostly due to uterine atony (73.3%). Mean baseline and nadir haemoglobin were 111 g/L (±18) and 62 g/L (±7.7), respectively. Multiple unit initial transfusion was found in a majority of patients (63.7%). Iron therapy was administered to 51.5% of women in-hospital and 81.9% received an oral iron prescription at discharge. There were no differences in primary or secondary outcomes subsequent to relevant guideline publication. Our centre's compliance rate for RBC transfusion indication meets current practice guidelines. Areas for improvement include single-unit initial transfusion protocols and adjuvant iron treatment. Antenatal optimization of haemoglobin and ferritin stores may limit postpartum transfusions.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Postpartum anaemia is a prevalent health problem. We aimed to determine the compliance rate for red blood cell (RBC) transfusion indication among postpartum women in a single tertiary care centre in Quebec, Canada.
MATERIALS AND METHODS
METHODS
Retrospective cohort study including all women ≥6 h postpartum who received ≥1 RBC transfusion during their delivery hospitalization between January 2005 and February 2022. We determined our centre's compliance rate by indication as compared to current society guidelines, all published after 2015 (Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis [NATA], Royal College of Obstetricians and Gynaecologists [RCOG], American College of Obstetricians and Gynecologists [ACOG]). We then explored predictors of guideline non-compliance and described transfusion practices in our centre.
RESULTS
RESULTS
A total of 171 women were included. Our centre's compliance rate was 79.5% (95% confidence interval [CI] 72.7-84.8). Predictors of guideline non-compliance were maternal medical comorbidity or abnormal placentation, both limited by large CIs (odds ratio [OR] 2.26, CI 1.02-4.94, p = 0.04; OR 4.00, CI 1.31-12.06, p = 0.01, respectively). Postpartum haemorrhage was diagnosed among 68% of the cohort, mostly due to uterine atony (73.3%). Mean baseline and nadir haemoglobin were 111 g/L (±18) and 62 g/L (±7.7), respectively. Multiple unit initial transfusion was found in a majority of patients (63.7%). Iron therapy was administered to 51.5% of women in-hospital and 81.9% received an oral iron prescription at discharge. There were no differences in primary or secondary outcomes subsequent to relevant guideline publication.
CONCLUSION
CONCLUSIONS
Our centre's compliance rate for RBC transfusion indication meets current practice guidelines. Areas for improvement include single-unit initial transfusion protocols and adjuvant iron treatment. Antenatal optimization of haemoglobin and ferritin stores may limit postpartum transfusions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.
Références
Milman N. Postpartum anemia II: prevention and treatment. Ann Hematol. 2012;91:143–154.
Parker J, Thompson J, Stanworth S. A retrospective one‐year single‐centre survey of obstetric red cell transfusions. Int J Obstet Anesth. 2009;18:309–313.
Butwick AJ, Aleshi P, Fontaine M, Riley ET, Goodnough LT. Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. Int J Obstet Anesth. 2009;18:302–308.
Stephens B, Sethna F, Crispin P. Postpartum obstetric red cell transfusion practice: a retrospective study in a tertiary obstetric centre. Aust N Z J Obstet Gynaecol. 2018;58:170–177.
Cho GJ, Lee KM, Kim HY, Han SW, Oh MJ, Chiec L, et al. Postpartum haemorrhage requiring transfusion and risk of cardiovascular disease later in life: a retrospective cohort study. BJOG. 2021;128:738–744.
Thurn L, Wikman A, Lindqvist PG. Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism. Thromb Res. 2018;165:54–60.
Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink‐Bot ML, Uyl‐de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non‐inferiority trial. BJOG. 2014;121:1005–1014.
Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021;12:CD002042.
Muñoz M, Peña‐Rosas JP, Robinson S, Milman N, Holzgreve W, Breymann C, et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post‐partum period: NATA consensus statement. Transfus Med. 2018;28:22–39.
RCOG. Blood transfusions in obstetrics (green‐top guideline no. 47). 2015. https://www.rcog.org.uk/guidance/browse‐all‐guidance/green‐top‐guidelines/blood‐transfusions‐in‐obstetrics‐green‐top‐guideline‐no‐47. Last accessed 18 Jun 2024.
Committee on Practice Bulletins‐Obstetrics. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol. 2017;130:e168–e186.
Using Blood Wisely: intervention toolbox. Available from: https://usingbloodwisely.ca/intervention/. Last accessed 18 Jun 2024.
Hamm RF, Perelman S, Wang EY, Levine LD, Srinivas SK. Single‐unit vs multiple‐unit transfusion in hemodynamically stable postpartum anemia: a pragmatic randomized controlled trial. Am J Obstet Gynecol. 2021;224:84.e1–84.e7.
Andrikopoulou M, D'Alton ME. Postpartum hemorrhage: early identification challenges. Semin Perinatol. 2019;43:11–17.
Smith C, Teng F, Branch E, Chu S, Joseph KS. Maternal and perinatal morbidity and mortality associated with anemia in pregnancy. Obstet Gynecol. 2019;134:1234–1244.
Tang G, Lausman A, Petrucci J, Abdulrehman J, Nisenbaum R, Hicks LK, et al. Prevalence of iron deficiency in pregnancy: a single Centre Canadian study. Blood. 2018;132:4896.
Malee M, American College of Obstetricians and Gynecologists', Committee on Practice Bulletins—Obstetrics. Anemia in pregnancy: ACOG practice bulletin, number 233. Obstet Gynecol. 2021;138:e55–e64.
Robinson D, Basso M, Chan C, Duckitt K, Lett R. Guideline no. 431: postpartum hemorrhage and hemorrhagic shock. J Obstet Gynaecol Can. 2022;44:1293–1310.e1.
Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, et al. Red blood cell transfusion: 2023 AABB international guidelines. JAMA. 2023;330:1892–1902.